Health & MedicineTop StoryTop StoryLatest News
New Weight-Loss Drug Can Help Treat Sleep Apnea, Study Reveals
Sentiment: NeutralHigh Priority
What Happened?
Retatrutide, an experimental weight-loss drug, shows promise in reducing sleep apnea symptoms, according to new clinical trial findings. The drug is still under investigation and not yet approved for routine use.
Key points
- Retatrutide may help individuals lose nearly twice as much weight as Ozempic.
- New Phase 3 clinical trials indicate significant reduction in sleep-related breathing interruptions.
- Dr. Loveleen Mangla emphasizes that improvements do not guarantee a cure for sleep apnea.
- Weight loss can alleviate symptoms of obstructive sleep apnea by reducing airway obstruction.
- Retatrutide acts on three hormone receptors influencing appetite and metabolism.
Key insights
- If retatrutide is approved, it may change the approach to treating sleep apnea.
- Patients should continue prescribed treatments like CPAP even after weight loss.
- The drug's effectiveness in sleep apnea treatment may prompt further research into similar medications.
Why it matters
The findings could lead to new treatment options for patients suffering from sleep apnea.
Source
Times Now
